The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy

Nature Medicine

Volumn 11, Issue 8, 2005, Pages 837-844

  Buitrago, Monika ^a,b   Lorenz, Kristina ^b   Maass, Alexander H ^b   Oberdorf Maass, Silke ^a   Keller, Ursula ^a   Schmitteckert, Eva M ^b   Ivashchenko, Yuri ^c   Lohse, Martin J ^b   Engelhardt, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REPRESSOR PROTEIN NAB1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; EXERCISE; GENE OVEREXPRESSION; HEART DEVELOPMENT; HEART FAILURE; HEART HYPERTROPHY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MAMMALIA; MUS MUSCULUS;

EID: 23844478203     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1272     Document Type: Article

References (35)

1. Towbin, J.A. & Bowles, N.E. The failing heart. Nature 415, 227-233 (2002).
2. Dorn, G.W., II, Robbins, J. & Sugden, P.H. Phenotyping hypertrophy: eschew obfuscation. Circ. Res. 92, 1171-1175 (2003).
3. Lohse, M.J., Engelhardt, S. & Eschenhagen, T. What is the role of b-adrenergic signaling in heart failure? Circ. Res. 93, 896-906 (2003).
4. Molkentin, J.D. & Dorn, I.G., II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63, 391-426 (2001).
5. Sussman, M.A. et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281, 1690-1693 (1998).
6. Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
7. Zhang, C.L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488 (2002).
8. Chien, K.R. & Olson, E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 110, 153-162 (2002).
9. Russo, M.W., Sevetson, B.R. & Milbrandt, J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl Acad. Sci. USA 92, 6873-6877 (1995).
10. Swirnoff, A.H. et al. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol. Cell. Biol. 18, 512-524 (1998).
11. Thiel, G. & Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 193, 287-292 (2002).
12. Warner, L.E. et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18, 382-384 (1998).
13. 1-adrenergic receptor transgenic mice. Proc. Natl Acad. Sc. USA 96, 7059-7064 (1999).
14. Topilko, P. et al. Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799 (1994).
15. Svaren, J. et al. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J. 17, 6010-6019 (1998).
16. Allen, D.L. et al. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J. Appl. Physiol. 90, 1900-1908 (2001).
17. Frey, N., Katus, H.A., Olson, E.N. & Hill, J.A. Hypertrophy of the heart: a new therapeutic target? Circulation 109, 1580-1589 (2004).
18. Esposito, G. et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105, 85-92 (2002).
19. Hill, J.A. et al. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function. J. Biol. Chem. 277, 10251-10255 (2002).
20. Rapacciuolo, A. et al. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol. 38, 876-882 (2001).
21. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B. & Castelli, W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566 (1990).
22. Yasukawa, H. et al. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Invest. 111, 469-478 (2003).
23. Rothermel, B.A. et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl Acad. Sci. USA 198, 3328-3333 (2001).
24. Bueno, O.F. et al. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ. Res. 88, 88-96 (2001).
25. Crackower, M.A. et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737-749 (2002).
26. Milbrandt, J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238, 797-799 (1987).
27. Svaren, J. et al. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferate and differentiative stimuli. Mol. Cell. Biol. 16, 3545-3553 (1996).
28. Gashler, A. & Sukhatme, V.P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191-224 (1995).
29. Lee, S.L. et al. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273, 1219-1221 (1996).
30. Neyses, L. et al. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J. Hypertens. 11, 927-934 (1993).
31. Neyses, L., Nouskas, J. & Vetter, H. Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. Biochem. Biophys. Res. Commun. 181, 22-27 (1991).
32. Sadoshima, J., Jahn, L., Takahashi, T., Kulik, T.J. & Izumo, S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J. Biol. Chem. 267, 10551-10560 (1992).
33. Saadane, N., Alpert, L. & Chalifour, L.E. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 278, H796-H805 (2000).
34. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
35. Buvoli, M. & Leinwand, L.A. Direct gene transfer into mouse heart. Methods Enzymol. 346, 134-142 (2002).